Invest now

Themis Medicare share price

High risk
  • 55%Low risk
  • 55%Moderate risk
  • 55%Balanced risk
  • 55%High risk
  • 55%Extreme risk
  • 104.70(0.67%)
    August 14, 2026 15:57:11 PM IST
    • NSE
    • BSE
  • Vol : 125.19 K (NSE + BSE)
    Last 20 day avg : 113.34 K
Themis Medicare is trading 0.67% upper at Rs 104.70 as compared to its last closing price. Themis Medicare has been trading in the price range of 105.50 & 101.20. Themis Medicare has given 4.22% in this year & -5.11% in the last 5 days. Themis Medicare has TTM P/E ratio 25.24 as compared to the sector P/E of 32.90.The company posted a net profit of 24.61 Crores in its last quarter.Listed peers of Themis Medicare include Aurobindo Pharma (0.08%), Neuland Laboratories (0.38%), Pfizer (-2.30%).The Mutual Fund holding in Themis Medicare was at -% in . The MF holding has - from the last quarter. The FII holding in Themis Medicare was at 0.01% in 30 Jun 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 17 Aug 2026, 08:06 AM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.30
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.25
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.48
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.40
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    866.33
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -11.85
    Indicates undervaluation
Price range
Day Range
Lowest
101.20
Highest
105.50
52 week range
Lowest
65.00
Highest
147.99
Themis Medicare Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Aurobindo Pharma
1,658.000.0895,397.6525.092.350.262.89
Neuland Laboratories
23,311.500.3829,918.9664.2812.620.1813.90
Pfizer
4,870.00-2.3022,954.3827.534.971.640.86
Unichem Laboratories
539.70-0.903,834.6654.271.53-2.40
Jagsonpal Pharmaceuticals
225.55-1.741,492.9634.275.431.122.39
Mutual Fund Ownership
View all
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.01
  • % of AUM 0.03
Themis Medicare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-13Quarterly Results
2026-05-28Audited Results & Final Dividend
2026-02-13Quarterly Results & issue of Warrants
2025-11-13Quarterly Results
2025-08-01Quarterly Results
About the company Themis Medicare
  • IndustryMajor Drugs
  • ISININE083B01024
  • BSE Code530199
  • NSE CodeTHEMISMED
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.
  • Management Info
  • Dinesh PatelExecutive Chairman of the Board
  • Sachin PatelChief Executive Officer, Managing Director, Executive Director
  • Tushar DalalChief Financial Officer
  • Nagraj MogaveeraInterim Company Secretary, Compliance Officer
Themis Medicare Share Price FAQs

Themis Medicare is trading at 104.70 as on Fri Aug 14 2026 10:27:11. This is 0.67% upper as compared to its previous closing price of 104.00.

The market capitalization of Themis Medicare is 964.29 Cr as on Fri Aug 14 2026 10:27:11.

The 52 wk high for Themis Medicare is 147.99 whereas the 52 wk low is 65.00

Themis Medicare can be analyzed on the following key metrics -

  • TTM P/E: 25.24
  • Sector P/E: 32.90
  • Dividend Yield: 0.48%
  • D/E ratio: -

Themis Medicare reported a net profit of 1.14 Cr in 2026.